Literature DB >> 30684169

Prenatal Alcohol Exposure Causes Adverse Cardiac Extracellular Matrix Changes and Dysfunction in Neonatal Mice.

Van K Ninh1, Elia C El Hajj1, Alan J Mouton1, Jason D Gardner2.   

Abstract

Fetal alcohol syndrome (FAS) is the most severe condition of fetal alcohol spectrum disorders (FASD) and is associated with congenital heart defects. However, more subtle defects such as ventricular wall thinning and cardiac compliance may be overlooked in FASD. Our studies focus on the role of cardiac fibroblasts in the neonatal heart, and how they are affected by prenatal alcohol exposure (PAE). We hypothesize that PAE affects fibroblast function contributing to dysregulated collagen synthesis, which leads to cardiac dysfunction. To investigate these effects, pregnant C57/BL6 mice were intraperitoneally injected with 2.9 g EtOH/kg dose to achieve a blood alcohol content of approximately 0.35 on gestation days 6.75 and 7.25. Pups were sacrificed on neonatal day 5 following echocardiography measurements of left ventricular (LV) chamber dimension and function. Hearts were used for primary cardiac fibroblast isolation or protein expression analysis. PAE animals had thinner ventricular walls than saline exposed animals, which was associated with increased LV wall stress and decreased ejection fraction. In isolated fibroblasts, PAE decreased collagen I/III ratio and increased gene expression of profibrotic markers, including α-smooth muscle actin and lysyl oxidase. Notch1 signaling was assessed as a possible mechanism for fibroblast activation, and indicated that gene expression of Notch1 receptor and downstream Hey1 transcription factor were increased. Cardiac tissue analysis revealed decreased collagen I/III ratio and increased protein expression of α-smooth muscle actin and lysyl oxidase. However, Notch1 signaling components decreased in whole heart tissue. Our study demonstrates that PAE caused adverse changes in the cardiac collagen profile and a decline in cardiac function in the neonatal heart.

Entities:  

Keywords:  Collagen; Fetal alcohol spectrum disorder; Fetal alcohol syndrome; Fibrosis; Heart; Notch1

Mesh:

Substances:

Year:  2019        PMID: 30684169      PMCID: PMC7261018          DOI: 10.1007/s12012-018-09503-8

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  63 in total

1.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

Authors:  Luika A Timmerman; Joaquín Grego-Bessa; Angel Raya; Esther Bertrán; José María Pérez-Pomares; Juan Díez; Sergi Aranda; Sergio Palomo; Frank McCormick; Juan Carlos Izpisúa-Belmonte; José Luis de la Pompa
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

2.  Calreticulin promotes proliferation and extracellular matrix expression through Notch pathway in cardiac fibroblasts.

Authors:  Xiaoying Fan; Yuan Yao; Yao Zhang
Journal:  Adv Clin Exp Med       Date:  2018-07       Impact factor: 1.727

3.  Influence of prenatal alcohol exposure on myocardial contractile function in adult rat hearts: role of intracellular calcium and apoptosis.

Authors:  Jun Ren; Loren E Wold; Melissa Natavio; Bonnie H Ren; John H Hannigan; Ricardo A Brown
Journal:  Alcohol Alcohol       Date:  2002 Jan-Feb       Impact factor: 2.826

Review 4.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

5.  Alcohol use and binge drinking among women of childbearing age - United States, 2011-2013.

Authors:  Cheryl H Tan; Clark H Denny; Nancy E Cheal; Joseph E Sniezek; Dafna Kanny
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-09-25       Impact factor: 17.586

6.  Alcohol inhibits smooth muscle cell proliferation via regulation of the Notch signaling pathway.

Authors:  David Morrow; John P Cullen; Weimin Liu; Paul A Cahill; Eileen M Redmond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-07       Impact factor: 8.311

7.  Do pediatricians recognize fetal alcohol spectrum disorders in children with developmental and behavioral problems?

Authors:  Pat Rojmahamongkol; Ayesha Cheema-Hasan; Carol Weitzman
Journal:  J Dev Behav Pediatr       Date:  2015-04       Impact factor: 2.225

8.  Activation of cardiac fibroblasts by ethanol is blocked by TGF-β inhibition.

Authors:  Brittany A Law; Wayne E Carver
Journal:  Alcohol Clin Exp Res       Date:  2013-03-25       Impact factor: 3.455

9.  Chronic alcohol exposure induces muscle atrophy (myopathy) in zebrafish and alters the expression of microRNAs targeting the Notch pathway in skeletal muscle.

Authors:  Andrew Khayrullin; Lauren Smith; Dhwani Mistry; Amy Dukes; Y Albert Pan; Mark W Hamrick
Journal:  Biochem Biophys Res Commun       Date:  2016-09-23       Impact factor: 3.575

10.  Embryonic Ethanol Exposure Dysregulates BMP and Notch Signaling, Leading to Persistent Atrio-Ventricular Valve Defects in Zebrafish.

Authors:  Swapnalee Sarmah; Pooja Muralidharan; James A Marrs
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

View more
  3 in total

1.  N-Acetylcysteine prevents the decreases in cardiac collagen I/III ratio and systolic function in neonatal mice with prenatal alcohol exposure.

Authors:  Van K Ninh; Elia C El Hajj; Martin J Ronis; Jason D Gardner
Journal:  Toxicol Lett       Date:  2019-08-16       Impact factor: 4.372

2.  Hippocampal transcriptome analysis following maternal separation implicates altered RNA processing in a mouse model of fetal alcohol spectrum disorder.

Authors:  Bonnie L J Alberry; Christina A Castellani; Shiva M Singh
Journal:  J Neurodev Disord       Date:  2020-05-16       Impact factor: 4.025

Review 3.  Pathophysiological Consequences of At-Risk Alcohol Use; Implications for Comorbidity Risk in Persons Living With Human Immunodeficiency Virus.

Authors:  Liz Simon; Scott Edwards; Patricia E Molina
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.